This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Jonathan Thevenet
Introduction
Jonathan Thevenet is an accomplished inventor based in Publier, France. He has made significant contributions to the field of neurological disorders through his innovative research and development of novel compounds. With a total of 2 patents to his name, Thevenet is recognized for his dedication to advancing medical science.
Latest Patents
Thevenet's latest patents include groundbreaking work on meroterpenoid compounds and polyketide compounds. The first patent focuses on meroterpenoid compounds for use in the prevention and treatment of neurological disorders. This invention relates to a compound that can promote lactate secretion, offering potential therapeutic benefits. The second patent addresses polyketide compounds and their derivatives, also aimed at preventing and treating neurological disorders. Similar to the first, this invention emphasizes the promotion of lactate secretion and includes compositions enriched with these compounds.
Career Highlights
Jonathan Thevenet is currently associated with Société des Produits Nestlé S.A., where he continues to explore innovative solutions in the health and nutrition sector. His work is pivotal in developing products that can improve the quality of life for individuals suffering from neurological conditions.
Collaborations
Throughout his career, Thevenet has collaborated with notable colleagues, including Denis Marcel Barron and Yann Ratinaud. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jonathan Thevenet's contributions to the field of neurological disorders through his innovative patents highlight his commitment to medical advancement. His work not only showcases his expertise but also reflects the potential for future breakthroughs in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
